By modulating these receptors, clozapine reduces leptin activity, increases ghrelin levels, and enhances neuropeptide Y (NPY) expression, ultimately promoting appetite and reducing lipolysis, leading to visceral fat accumulation.[17–20] Eventually, visceral fat accumulation can contribute to insulin resistance significantly. The gene discussed is LEP; the disease is Insulin resistance.